Read the ruling here.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
MANHATTAN — A federal judge in New York dismissed a securities fraud class action against a silicone gel breast implant manufacturer that allegedly neglected to disclose a possible link between its implants and a very rare cancer. Requiring disclosures of such uncertain information would flood investors with warnings about too many adverse possibilities.